![](/resources/images/visual/visual02.png)
![](/resources/images/visual/visual01.png)
![](/resources/images/visual/visual03.png)
![](/resources/images/visual/visual_m.png)
![](/resources/images/gel/gel0904.png)
![](/resources/images/gel/secret01.png)
![](/resources/images/gel/secret02.png)
![](/resources/images/gel/secret03.png)
![](/resources/images/gel/gel_bl.png)
![](/resources/images/movie/movie_tit1.png)
![](/resources/images/movie/movie_tit2.png)
![](/resources/images/visual/visual03.png)
References
- Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris, Khodaeiani et al, International Journal of Dermatology 2013, 52, 999–1004
- TOPICAL NICOTINAMIDE COMPARED WITH CLINDAMYCIN GEL IN THE TREATMENT OE INELAMMATORY ACNE VULGARIS, Shalita et ai, International Journal of Dermatology, Vol. 34, No. 6, June 1995, 435-6
광고심의필 : 2023-1685-003700
*부작용이 있을 수 있으니 첨부된 '사용상의 주의사항을 잘 읽고, 의사·약사와 상의하십시오